Navigation Links
ProUroCare Medical Secures $885,000 in Financing
Date:6/17/2010

MINNEAPOLIS, June 17 /PRNewswire-FirstCall/ -- ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD), a provider of proprietary imaging products, today announced that it has closed on a $885,000 private placement of debt financing.  The funding was provided by a small group of existing investors closely aligned with the company.  

The proceeds from the financing will be used to fund manufacturing and marketing scale-up activities, expand the company's existing intellectual property portfolio and form a scientific advisory board.  A portion of the funding will also be used to pay existing debt obligations and for general corporate purposes.

"This additional funding brings the total amount raised by the company since 2007 to more than $9.3 million," said CEO Rick Carlson.  "We are very pleased by the support that we continue to receive from investors for the ProUroScan™ prostate imaging system and the market opportunities that exist for this technology.  Our immediate focus is to ensure the successful processing of our de novo filing and the resulting FDA clearance for commercialization."

About ProUroCare Medical, Inc.

ProUroCare Medical, Inc. is a publicly traded company engaged in the business of developing innovative medical imaging products. The company's current focus is the ProUroScan prostate imaging system, which is used to document abnormalities of the prostate detected by a Digital Rectal Exam (DRE).  Based in Minneapolis, Minn., ProUroCare is quoted on the OTCBB.

Safe Harbor Statement

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of ProUroCare's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause ProUroCare's results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the ability of ProUroCare to find adequate financing to complete the development of its products; the high level of secured and unsecured debt incurred by ProUroCare; the dependence by ProUroCare on third parties for the development and manufacture of its products; and other risks and uncertainties detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q. ProUroCare undertakes no duty to update any of these forward-looking statements.


'/>"/>
SOURCE ProUroCare Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010
2. ProUroCare Medical Announces Filing of Request to Classify the Prostate Mechanical Imager ("PMI") as a Class II Device
3. ProUroCare Medical Elects Two New Directors
4. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
5. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
6. ProUroCare Medical Inc. Announces Pricing of Equity Offering
7. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
8. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
9. Varian Medical Systems Equips International Oncologys First Comprehensive Cancer Center in India
10. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
11. Halt Medical, Inc. Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
(Date:3/1/2017)... 1, 2017  The Pharmaceutical Care Management Association (PCMA) ... vote to advance the nomination of Seema Verma ... Services Administrator: "The popular Medicare Part ... American health care. By offering an abundance of competing ... tools like pharmacy networks and home delivery, the program ...
(Date:3/1/2017)... -- The global  Intraoperative Neuromonitoring (IONM) market  is expected to reach ... Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in ... in a wide spectrum of surgeries. Continue Reading ... ... ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... The Industrial Designers Society of America (IDSA) ... awareness of the profession of industrial design (ID) and relaunching "What Is ID?" ... school students and counselors; parents; and the greater public. , Share details and photos ...
(Date:3/1/2017)... Philadelphia, Pennsylvania (PRWEB) , ... March 01, 2017 , ... ... the Bucci Law Firm, filed a civil sex abuse lawsuit in the Circuit Court ... adult males, who have only been identified by their initials. See L.B. and T.B. ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living and leading a healthy ... Go. , Time & Go app is the ultimate strategic compass that helps users ... management methods enable people to work smarter, not harder, that's why Time & Go ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... special pricing in the month of March for treatments aimed at tightening skin ... features use on Thermage skin tightening, with 30 percent off all Thermage face ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Marriage...God's Way: Key To One ... Key To One Flesh” is the creation of published author Cecilia Chiam, a writer ... Publishing, Cecilia Chiam‘s new book presents solutions to many marital problems with the guidance ...
Breaking Medicine News(10 mins):